Recently, G-CSF levels in tears have been identified as a predictive factor for CAD in patients with suspected CAD [18]; however, once again, the number of studies exploring G-CSF as an inflammatory biomarker related to cardiometabolic diseases is limited. The gene discussed is CSF3; the disease is coronary artery disorder.